COMP <GO>
ATRC vs PLSE // FREE CASH FLOW YIELD
AtriCure Inc. (NASDAQ) VS. Pulse Biosciences Inc (NASDAQ) • 15-METRIC TALLY: ATRC 7
— PLSE 1
▲ FREE CASH FLOW YIELD LEADER: ATRC
LAST: $61.25 (-1.97%) • MKT CAP: $3.18B
fcf-yield
1.52%
LAST: $52.24 (-5.84%) • MKT CAP: $3.96B
fcf-yield
-1.38%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ATRC VS. PLSE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ATRC | PLSE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.00% | -30.00% | +105.00 | ATRC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -1.90% | -30.70% | +28.80 | ATRC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 1.52% | -1.38% | +2.90 | ATRC | /fcf-yield <GO> |
| Operating Margin | -1.80% | -60.00% | +58.20 | ATRC | /operating-margins <GO> |
| Net Profit Margin | -2.10% | -60.00% | +57.90 | ATRC | /net-margins <GO> |
| Revenue Growth (YoY) | 14.90% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.08 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 2/9 | +6.00 | ATRC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.0 | 59.7 | +6.30 | ATRC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.18B | $3.96B | -$778.9M | PLSE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ATRC REV | PLSE REV | ATRC GROSS % | PLSE GROSS % | ATRC FCF | PLSE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $534.5M | $350.0K | 75.0% | -50.0% | $48.3M | -$54.4M |
| FY 2024 | $465.3M | $0 | 74.7% | — | $745.0K | -$36.5M |
| FY 2023 | $399.2M | $0 | — | — | $4.5M | -$33.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ATRC // BETA —
PLSE // BETA —